Christian M Gill

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 23

Top Topics

Pseudomonas Aeruginosa

Multidrug Resistant

Hematopoietic Stem Cell

Top Venues

The Journal of antimicrobial chemotherapy

Annals of hematology

Emerging microbes & infections

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Emily L Gill, Christian M Gill, Colleen McEvoy
Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population. Annals of hematology 103 (5) (2024)
Emily L Gill, Christian M Gill, Colleen McEvoy
Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population. Annals of hematology 103 (5) (2024)
Christian M Gill, Debora Santini, David P Nicolau, null null
In vitro activity of cefiderocol against a global collection of carbapenem-resistant Pseudomonas aeruginosa with a high level of carbapenemase diversity. The Journal of antimicrobial chemotherapy 79 (2) (2024)
Emily L Gill, Christian M Gill, Colleen McEvoy
Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population. Annals of hematology 103 (5) (2024)
Aliaa Fouad, Samantha E Nicolau, Pranita D Tamma, Patricia J Simner, David P Nicolau, Christian M Gill
Assessing the impact of meropenem exposure on ceftolozane/tazobactam-resistance development in Pseudomonas aeruginosa using in vitro serial passage. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Emily L Gill, Christian M Gill, Colleen McEvoy
Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population. Annals of hematology 103 (5) (2024)
Aliaa Fouad, Samantha E Nicolau, Pranita D Tamma, Patricia J Simner, David P Nicolau, Christian M Gill
Assessing the impact of meropenem exposure on ceftolozane/tazobactam-resistance development in Pseudomonas aeruginosa using in vitro serial passage. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Victor H Ruiz, Christian M Gill, David P Nicolau
Assessing the in vivo impact of novel β-lactamase inhibitors on the efficacy of their partner β-lactams against serine carbapenemase-producing Pseudomonas aeruginosa using human-simulated exposures. The Journal of antimicrobial chemotherapy 79 (3) (2024)
Aliaa Fouad, Samantha E Nicolau, Pranita D Tamma, Patricia J Simner, Yasmeen Abouelhassan, Christian M Gill
Assessing the impact of meropenem exposure on ceftolozane/tazobactam-resistance development in Pseudomonas aeruginosa using in vitro serial passage. The Journal of antimicrobial chemotherapy (2024)
Emily L Gill, Christian M Gill, Colleen McEvoy
Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population. Annals of hematology 103 (5) (2024)
Victor H Ruiz, Christian M Gill, David P Nicolau
Assessing the in vivo impact of novel β-lactamase inhibitors on the efficacy of their partner β-lactams against serine carbapenemase-producing Pseudomonas aeruginosa using human-simulated exposures. The Journal of antimicrobial chemotherapy 79 (3) (2024)
Emily L Gill, Christian M Gill, Colleen McEvoy
Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population. Annals of hematology (2024)
Christian M Gill, Debora Santini, David P Nicolau, null null
In vitro activity of cefiderocol against a global collection of carbapenem-resistant Pseudomonas aeruginosa with a high level of carbapenemase diversity. The Journal of antimicrobial chemotherapy 79 (2) (2024)
Victor H Ruiz, Christian M Gill, Yasmeen Abouelhassan
Assessing the in vivo impact of novel β-lactamase inhibitors on the efficacy of their partner β-lactams against serine carbapenemase-producing Pseudomonas aeruginosa using human-simulated exposures. The Journal of antimicrobial chemotherapy (2024)
Christian M Gill, Debora Santini, David P Nicolau, null null
In vitro activity of cefiderocol against a global collection of carbapenem-resistant Pseudomonas aeruginosa with a high level of carbapenemase diversity. The Journal of antimicrobial chemotherapy 79 (2) (2024)
Emily L Gill, Christian M Gill, Colleen McEvoy
Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population. Annals of hematology 103 (5) (2024)
Aliaa Fouad, Yasmeen Abouelhassan, Christian M Gill
In vitro synergy of the combination of sulbactam-durlobactam and cefepime at clinically relevant concentrations against A. baumannii, P. aeruginosa and Enterobacterales. The Journal of antimicrobial chemotherapy (2023)
Christian M Gill, David P Nicolau
In Vivo Pharmacodynamic Profile of EVER206, a Novel Polymyxin Antimicrobial, against Gram-Negative Bacteria in the Murine Thigh Infection Model. Antimicrobial agents and chemotherapy (2023)
Su Young Lee, Christian M Gill, David P Nicolau, null null
Activity of novel β-lactam/β-lactamase inhibitor combinations against serine carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy (2023)
Christian M Gill, Poonam Rajkotia, Amity L Roberts, Fred C Tenover, David P Nicolau
Directed carbapenemase testing is no longer just for Enterobacterales: cost, labor, and workflow assessment of expanding carbapenemase testing to carbapenem-resistant P. aeruginosa . Emerging microbes & infections 12 (1) (2023)
Christian M Gill, Debora Santini, David P Nicolau, null null
In vitro activity of cefiderocol against a global collection of carbapenem-resistant Pseudomonas aeruginosa with a high level of carbapenemase diversity. The Journal of antimicrobial chemotherapy (2023)
Christian M Gill, Poonam Rajkotia, Amity L Roberts, Fred C Tenover, David P Nicolau
Directed carbapenemase testing is no longer just for Enterobacterales: cost, labor, and workflow assessment of expanding carbapenemase testing to carbapenem-resistant P. aeruginosa . Emerging microbes & infections 12 (1) (2023)
Christian M Gill, Rachel M Kenney, Charles T Makowski, Susan L Davis
High-Dose Daptomycin Is Well Tolerated via 2-Minute IV Push Administration. Hospital pharmacy 56 (4) (2020)